M. Hashimoto et Je. Wilson, Membrane potential-dependent conformational changes in mitochondrially bound hexokinase of brain, ARCH BIOCH, 384(1), 2000, pp. 163-173
Previously characterized monoclonal antibodies (Mabs) were used in a study
of Type I hexokinase from rat brain. Based on the relative reactivity of th
ese Mabs with soluble and mitochondrially bound forms, binding to mitochond
ria was shown to affect specific epitopic regions in both N- and C-terminal
halves of the enzyme and to modulate conformational changes induced by bin
ding of the ligands, Glc or ATP. Reactivities with Mabs recognizing epitope
s in two defined regions of the N-terminal half and one defined region of t
he C-terminal half of the mitochondrially bound enzyme were selectively aff
ected by mitochondrial membrane potential, or by addition of oligomycin, ca
rboxyatractyloside, or bongkrekic acid. The GIc-6-P analog, 1,5-anhydrogluc
itol-6-P, was much more effective as a competitive inhibitor against extram
itochondrial ATP than against intramitochondrial ATP generated by oxidative
phosphorylation, These results provide further insight into the role of he
xokinase-mitochondrial interactions in regulation of cerebral glucose metab
olism. (C) 2000 Academic Press.